Podcast
Revi Talks
Conversations on living longer, healthier lives. Revi Talks is Revi Health's podcast on regenerative medicine, hormonal health, metabolic health and longevity. We speak with leading clinicians, researchers and patients about what actually works.
Should you take peptides?
The premiere of Revi Talks. A thorough introduction to peptides: what they are, what they do in the body, and when they may be warranted.
Should you take peptides for weight loss?
GLP-1, tirzepatide and other peptides for weight loss — what works, what are the risks, and how do we think about muscle mass and long-term health?
Can peptides heal the body?
We unpack what peptides actually are, how they're used in regenerative medicine, and what the evidence says about healing tissue, joints and tendons.
Sick of lipids!
We're sick of lipids. Or rather, sick of the endless lipid debate.
Training, sleep, blood work and supplements — we answer your questions
What actually matters? We answer your questions on training, sleep, blood work and supplements — separating what's backed by evidence from what's just noise.
20 years of elite sport — motivation or obsession?
What does 20 years at the elite level really take? We explore the line between healthy drive and unhealthy obsession — and what it does to the body, hormones and recovery over time.
Immunomodulating peptides: hype, substance and the future of medicine
Markus and Johan on immunomodulating peptides — Thymosin Alpha-1, KPV, LL-37 and VIP. What does the evidence say, where does the FDA draw the line, and what's substance versus hype in the longevity field?
Tier list: diagnostic tools and screening tests
A tier list of diagnostic tools — from blood work and DEXA to whole-body MRI, liquid biopsy and CGM. What gives signal, what's noise, and when does a test actually change what you do about your health?
Q&A: 30+ questions on longevity, healthspan and aging
A pure Q&A round: we answer 30+ questions on longevity, healthspan and the biology of aging — from hearing checks and shingles vaccines to creatine, GLP-1, TRT, rapamycin and senolytics.
The peptides promising more energy – from hype to FDA approval
A mitochondrial peptide is now FDA-approved — and suddenly half the biohacking world wants it off-label. We unpack what these peptides actually do, how far the evidence reaches, and where promising hypothesis ends and proven effect begins.